![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 9/96 | |
A61K 38/48 | |||
A61K 38/36 |
(11) | Number of the document | 2591099 |
(13) | Kind of document | T |
(96) | European patent application number | 11738538.5 |
Date of filing the European patent application | 2011-07-11 | |
(97) | Date of publication of the European application | 2013-05-15 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/043597 |
Date | 2011-07-11 |
(87) | Number | WO 2012/006633 |
Date | 2012-01-12 |
(30) | Number | Date | Country code |
201161442055 P | 2011-02-11 | US | |
201161467880 P | 2011-03-25 | US | |
363183 P | 2010-07-09 | US | |
201161491762 P | 2011-05-31 | US | |
201161442150 P | 2011-02-11 | US | |
363186 P | 2010-07-09 | US | |
201161442029 P | 2011-02-11 | US |
(72) |
SALAS, Joe, US
PETERS, Robert, US
BITONTI, Alan, US
|
(73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
(54) | CHIMERIC CLOTTING FACTORS |
CHIMERIC CLOTTING FACTORS |